HomeTrialNCT06236750
🔬NCT06236750NARECRUITING

Post-Marketing Surveillance of Dehydrated Human Amnion/Chorion Membrane (DHACM) in Non-Ischemic Chronic Wounds

Study Summary

The purpose of this survey is to observe the efficacy and safety of EPIFIX® dehydrated human amnion/chorion membrane (DHACM) for the treatment of intractable diabetic foot ulcers or venous leg ulcers.

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment75 participants
Primary Completion
Lead SponsorMiMedx Group, Inc.
Data Retrieved2026-04-11 04:20:58.628818+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.